1. P1–342: Effects of solanezumab versus placebo administration on biomarkers in people with mild‐to‐moderate Alzheimer's disease: Results from two phase III clinical trials. (1st July 2013) Authors: Dean, Robert; Siemers, Eric; Carlson, Christopher; Estergard, Wahiba; Sundell, Karen; Henley, David; Hake, Ann; Eads, Jennifer; Sexton, Cora; Liu‐Seifert, Hong; Sethuraman, Gopalan; Chen, Yun‐Fei; Gonzales, Celedon; Lachno, D. Richard; Gelfanova, Valentina; Talbot, Jayne; Racke, Margaret; Mintun,... Journal: Alzheimer's & dementia Issue: Volume 9:Supplement 4S(2013)Part 7 Page Start: P283 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗